KIA
GSK icon

KCM Investment Advisors’s GSK GSK Stock Holding History

KCM Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,323
Closed -$211K – 532
2018
Q1 		$211K Sell
4,323
-948
-18% -$44.1K 0.01% 497
2017
Q4 		$234K Sell
5,271
-356
-6% -$16.4K 0.01% 473
2017
Q3 		$286K Buy
5,627
+203
+4% +$10.3K 0.02% 440
2017
Q2 		$292K Sell
5,424
-15,170
-74% -$809K 0.02% 445
2017
Q1 		$1.08M Sell
20,594
-2,681
-12% -$136K 0.07% 243
2016
Q4 		$1.12M Sell
23,275
-615
-3% -$30.4K 0.08% 240
2016
Q3 		$1.29M Buy
23,890
+648
+3% +$35.5K 0.09% 226
2016
Q2 		$1.26M Buy
23,242
+48
+0.2% +$2.53K 0.09% 222
2016
Q1 		$1.18M Sell
23,194
-4,676
-17% -$233K 0.09% 219
2015
Q4 		$1.41M Sell
27,870
-2,960
-10% -$151K 0.11% 200
2015
Q3 		$1.48M Sell
30,830
-2,616
-8% -$136K 0.12% 198
2015
Q2 		$1.74M Sell
33,446
-2,096
-6% -$118K 0.14% 192
2015
Q1 		$2.05M Sell
35,542
-252
-0.7% -$14.4K 0.16% 164
2014
Q4 		$1.91M Sell
35,794
-5,938
-14% -$332K 0.16% 161
2014
Q3 		$2.4M Sell
41,732
-278
-0.7% -$17K 0.22% 130
2014
Q2 		$2.81M Sell
42,010
-490
-1% -$33.2K 0.26% 110
2014
Q1 		$2.84M Sell
42,500
-894
-2% -$60.4K 0.29% 104
2013
Q4 		$2.9M Sell
43,394
-477
-1% -$30.9K 0.32% 97
2013
Q3 		$2.75M Sell
43,871
-9,094
-17% -$585K 0.33% 94
2013
Q2 		$3.31M Buy
+52,965
New +$3.36M 0.4% 72

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KCM Investment Advisors's GSK Position: Q2 2018 in Review

KCM Investment Advisors sold out of GSK (GSK) in Q2 2018, closing a stake of 4,323 shares — an estimated $211K sold.

KCM Investment Advisors first reported a position in GSK in Q2 2013 and held it in 20 quarters. The position peaked at $3.31M in Q2 2013. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

  • KCM Investment Advisors reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
  • KCM Investment Advisors sold 4,323 GSK shares in Q2 2018, an estimated $211K.
  • KCM Investment Advisors first reported a position in GSK in Q2 2013 and held it in 20 quarters.
  • KCM Investment Advisors's GSK position peaked at $3.31M in Q2 2013.
  • 787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on KCM Investment Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.